Laura Burke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Burke has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Rebecca L. Jones
Leeds Liver Unit, St James’s University Hospital, Leeds, UK
4 shared publications - Andrew Yeoman
Gwent Liver Unit, Aneurin Bevan University Health Board, Newport, UK
3 shared publications Conor Braniff
Department of Hepatology, Regional Liver Unit, Belfast Health and Social Care Trust, Belfast, UK
3 shared publications- Joanna Leithead
Forth Valley Royal Hospital, Larbert, UK
3 shared publications - Richard James Aspinall
Department of Gastroenterology and Hepatology, Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK
3 shared publications Collette Thain
PBC Foundation, Edinburgh, UK
2 shared publications
Latest Publications
- 18 September 2026
- Published by BMJ in Frontline Gastroenterology
How to manage: acute-on-chronic liver failure
Acute on chronic liver failure has emerged as a distinct clinical entity over the past few decades. While mortality remains highest for patients who develop liver and multiple non-liver organ failures, earlier recognition of the syndrome, including identification and management of precipitating factors, as well as a systematic approach to the management of organ failures, is leading to improved patient outcomes. Liver transplantation has emerged as a life-saving intervention for some patients but requires timely prognostication and discussion with local transplant centres. In this review, we aim to provide a practical summary to support the management of this patient cohort.
- 18 September 2026
- Published by BMJ in Frontline Gastroenterology
How to manage: acute-on-chronic liver failure
Acute on chronic liver failure has emerged as a distinct clinical entity over the past few decades. While mortality remains highest for patients who develop liver and multiple non-liver organ failures, earlier recognition of the syndrome, including identification and management of precipitating factors, as well as a systematic approach to the management of organ failures, is leading to improved patient outcomes. Liver transplantation has emerged as a life-saving intervention for some patients but requires timely prognostication and discussion with local transplant centres. In this review, we aim to provide a practical summary to support the management of this patient cohort.
- Open Access
- 10 April 2025
- Published by Elsevier in JHEP Reports
- Vol. 7 (9) , 101422
Implementation of a care bundle improves PBC management
- 10 April 2025
- Published by Elsevier in JHEP Reports
- Vol. 7 (9) , 101422
Open AccessImplementation of a care bundle improves PBC management
- 29 January 2025
- Published by Elsevier in Journal of Hepatology
- Vol. 82 (5) , e260-e262
Reply to: Correspondence on ‘Plasma exchange does not improve overall survival in patients with acute liver failure in a real world cohort’
- 29 January 2025
- Published by Elsevier in Journal of Hepatology
- Vol. 82 (5) , e260-e262
Reply to: Correspondence on ‘Plasma exchange does not improve overall survival in patients with acute liver failure in a real world cohort’
- Open Access
- 13 October 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 46, 101067
Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisation
- 13 October 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 46, 101067
Open AccessLiver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisation
- Open Access
- 9 October 2024
- Published by Elsevier in JHEP Reports
- Vol. 7 (1) , 101227
Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis
- 9 October 2024
- Published by Elsevier in JHEP Reports
- Vol. 7 (1) , 101227
Open AccessHepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis
- 1 October 2024
- Published by Elsevier in Journal of Hepatology
- Vol. 82 (4) , 615-621
Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort
- 1 October 2024
- Published by Elsevier in Journal of Hepatology
- Vol. 82 (4) , 615-621
Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort
- Open Access
- 16 October 2023
- Published by Elsevier in JHEP Reports
- Vol. 6 (1) , 100931
Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery
- 16 October 2023
- Published by Elsevier in JHEP Reports
- Vol. 6 (1) , 100931
Open AccessCritical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery
- 23 June 2022
- Published by BMJ in Frontline Gastroenterology
- Vol. 14 (2) , 175.1-175
UK-PBC National Audit: a collaborative success in identifying critical shortfalls
- 23 June 2022
- Published by BMJ in Frontline Gastroenterology
- Vol. 14 (2) , 175.1-175
UK-PBC National Audit: a collaborative success in identifying critical shortfalls
- Open Access
- 2 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25609
The National Audit of Primary Biliary Cholangitis (PBC) in the United Kingdom: Defining the Audit Dataset and Data Collection System
Primary biliary cholangitis (PBC) is a debilitating chronic liver disease that progresses to cirrhosis with attendant complications in a substantial proportion of patients. It is a major cause of liver-related morbidity and mortality in the United Kingdom (UK). The British Society of Gastroenterology (BSG) published guidelines on PBC management, which included key audit standards. Therefore, we propose the first UK-wide audit of the management of PBC, sanctioned by the BSG and the British Association for Study of the Liver (BASL), to benchmark NHS trusts and health boards against these audit standards as a guide to targeted improvement in the delivery of PBC-related health care.
- 2 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25609
Open AccessThe National Audit of Primary Biliary Cholangitis (PBC) in the United Kingdom: Defining the Audit Dataset and Data Collection System
Primary biliary cholangitis (PBC) is a debilitating chronic liver disease that progresses to cirrhosis with attendant complications in a substantial proportion of patients. It is a major cause of liver-related morbidity and mortality in the United Kingdom (UK). The British Society of Gastroenterology (BSG) published guidelines on PBC management, which included key audit standards. Therefore, we propose the first UK-wide audit of the management of PBC, sanctioned by the BSG and the British Association for Study of the Liver (BASL), to benchmark NHS trusts and health boards against these audit standards as a guide to targeted improvement in the delivery of PBC-related health care.